Guggenheim Maintains Buy on Smartsheet, Raises Price Target to $54
Guggenheim analyst John Difucci maintains Smartsheet (NYSE:SMAR) with a Buy and raises the price target from $48 to $54.
Guggenheim Maintains Buy on RAPT Therapeutics, Lowers Price Target to $48
Guggenheim analyst Yatin Suneja maintains RAPT Therapeutics (NASDAQ:RAPT) with a Buy and lowers the price target from $55 to $48.
B of A Securities Upgrades Discover Finl to Neutral, Announces $107 Price Target
B of A Securities analyst Mihir Bhatia upgrades Discover Finl (NYSE:DFS) from Underperform to Neutral and announces $107 price target.
Barrington Research Reiterates Outperform on American Public Education, Lowers Price Target to $10
Barrington Research analyst Alexander Paris reiterates American Public Education (NASDAQ:APEI) with a Outperform and lowers the price target from $15 to $10.
Expert Ratings for ShockWave Medical
ShockWave Medical (NASDAQ:SWAV) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Guggenheim Reiterates Buy on Larimar Therapeutics, Maintains $12 Price Target
Guggenheim analyst Yatin Suneja reiterates Larimar Therapeutics (NASDAQ:LRMR) with a Buy and maintains $12 price target.
Goldman Sachs Maintains Neutral on Ecopetrol, Lowers Price Target to $11
Goldman Sachs analyst Bruno Amorim maintains Ecopetrol (NYSE:EC) with a Neutral and lowers the price target from $12.4 to $11.
EF Hutton Maintains Buy on BRT Apartments, Lowers Price Target to $25
EF Hutton analyst Gaurav Mehta maintains BRT Apartments (NYSE:BRT) with a Buy and lowers the price target from $27 to $25.
Wolfe Research Maintains Outperform on Meta Platforms, Raises Price Target to $230
Wolfe Research analyst Deepak Mathivanan maintains Meta Platforms (NASDAQ:META) with a Outperform and raises the price target from $220 to $230.
JP Morgan Maintains Overweight on New York Times, Raises Price Target to $41
JP Morgan analyst David Karnovsky maintains New York Times (NYSE:NYT) with a Overweight and raises the price target from $38 to $41.